Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Laekna announces first IND clearance by U.S. FDA for internally-discovered LAE102 2023-05-21 22:23
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' 2023-05-20 00:55
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 21:00
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease 2023-05-19 19:00
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™) 2023-05-19 16:34
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
Asieris Deepens Strategic Partnership with UroViu to Further Develop Integrated Diagnosis and Treatment Platform for Bladder Cancer 2023-05-18 16:00
Antengene Announces Clearance of U.S. IND for the Phase I Trial of First-in-Class Anti-CD24 Monoclonal Antibody ATG-031 2023-05-18 02:47
Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023 2023-05-17 18:00
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022 2023-05-17 05:00
Fresh2 Reports Fiscal Year 2022 Annual Financial Results 2023-05-17 04:15
Eluminex Biosciences Receives Scientific Recognition for its Recombinant Human Collagen (rhCIII) Biosynthetic Cornea (EB-301) Program to Treat Corneal Blindness 2023-05-16 23:00
The first spring CMEF exhibition after the COVID-19 pandemic in the Chinese mainland: A brief discussion on the rise and challenges of China's domestic medical apparatus from Diagens Biotechnology 2023-05-16 21:39
WuXi Biologics Announces Manufacturing Partnership with InflaRx to Advance Gohibic for the Treatment of Certain Critically Ill COVID-19 patients 2023-05-16 16:00
ChomiX Biotech Announces millions of dollars Series Pre-A+ Financing to accelerate the development of Chemoproteomics Platform 2023-05-15 20:00
Gracell Biotechnologies Initiates Investigational Study Evaluating GC012F for Treatment of Refractory Systemic Lupus Erythematosus (SLE) 2023-05-15 19:00
LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate 2023-05-12 23:30
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion 2023-05-12 21:00
Nona Biosciences Announces Strategic Collaboration Agreement with PharmaEssentia Innovation Research Center 2023-05-12 09:32
Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in RRMM and B-NHL and Donor-Derived CAR-T GC007g in B-ALL at EHA2023 Congress 2023-05-12 05:28
1 52 53 54 55 56 222